BRPI0812040A2 - Indicações para terapia de anti-il-i-beta - Google Patents

Indicações para terapia de anti-il-i-beta

Info

Publication number: BRPI0812040A2
Authority: BR; Brazil
Prior art keywords: indications; beta therapy; beta; therapy
Prior art date: 2007-05-29

Application number

BRPI0812040-4A2A

Other languages

English (en)

Inventor

Hermann Gram

Thomas Jung

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-29

Filing date

2008-05-28

Publication date

2014-10-21

2008-05-28 Application filed by Novartis Ag filed Critical Novartis Ag

2014-10-21 Publication of BRPI0812040A2 publication Critical patent/BRPI0812040A2/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/245—IL-1
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Transplantation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0812040-4A2A 2007-05-29 2008-05-28 Indicações para terapia de anti-il-i-beta BRPI0812040A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07109084		2007-05-29
PCT/EP2008/056520 WO2008145664A1 (en)	2007-05-29	2008-05-28	New indications for anti- il-i-beta therapy

Publications (1)

Publication Number	Publication Date
BRPI0812040A2 true BRPI0812040A2 (pt)	2014-10-21

Family

ID=38626983

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0812040-4A2A BRPI0812040A2 (pt)	2007-05-29	2008-05-28	Indicações para terapia de anti-il-i-beta

Country Status (11)

Country	Link
US (8)	US8282922B2 (pt)
EP (5)	EP2152308A1 (pt)
JP (7)	JP2010528086A (pt)
KR (7)	KR20160017119A (pt)
CN (2)	CN101678104A (pt)
AU (1)	AU2008257520B2 (pt)
BR (1)	BRPI0812040A2 (pt)
CA (8)	CA2947947C (pt)
MX (1)	MX2009012948A (pt)
RU (2)	RU2009148597A (pt)
WO (1)	WO2008145664A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP20230776T1 (hr)	2010-07-29	2023-10-27	Buzzard Pharmaceuticals AB	Himerni antagonisti receptora il-1 tipa i
CN104474546A (zh) *	2010-08-13	2015-04-01	弗·哈夫曼-拉罗切有限公司	用于疾病治疗的针对IL-1β和IL-18的抗体
WO2012034039A2 (en) *	2010-09-10	2012-03-15	Apexigen, Inc.	Anti-il-1 beta antibodies and methods of use
CN103059136A (zh) *	2012-12-24	2013-04-24	浙江大学	抗中华鳖IL-1β多克隆抗体的制备及在检测中的应用
JP6450364B2 (ja)	2013-03-13	2019-01-09	セセンバイオ，インコーポレイテッド	眼送達のためのキメラサイトカイン製剤
JP6456015B2 (ja) *	2013-07-19	2019-01-23	国立大学法人三重大学	閉塞性動脈硬化症モデル動物、るい痩研究用モデル動物、及び全身性アミロイドーシスモデル動物としての非ヒト哺乳動物
UY37758A (es)	2017-06-12	2019-01-31	Novartis Ag	Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos
CN118175298A (zh)	2018-04-02	2024-06-11	Lg电子株式会社	图片解码方法、图片编码方法和发送方法
CN110818793A (zh) *	2018-08-14	2020-02-21	中山康方生物医药有限公司	抗IL-1β的抗体、其药物组合物及其用途
WO2021150266A1 (en)	2020-01-21	2021-07-29	Tavotek Biotherapeutics (Hong Kong) Limited	Agents that interfere with il-1beta receptor signalling
CA3201637A1 (en)	2020-11-18	2022-05-27	Novartis Ag	Bispecific antibodies for use in treatment of nlrc4-gof inflammasomapathy
US20240158490A1 (en)	2022-11-11	2024-05-16	Jeff R. Peterson	Gout flare prevention methods using il-1beta blockers
US12269875B2 (en) *	2023-08-03	2025-04-08	Jeff R. Peterson	Gout flare prevention methods using IL-1BETA blockers
WO2025071159A1 (ko)	2023-09-27	2025-04-03	주식회사 엘지에너지솔루션	전고체 전지용 양극 및 이를 포함하는 전고체 전지
JP2025165487A (ja)	2024-04-23	2025-11-05	セイコーエプソン株式会社	シート製造装置

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8823869D0 (en)	1988-10-12	1988-11-16	Medical Res Council	Production of antibodies
EP1690935A3 (en)	1990-01-12	2008-07-30	Abgenix, Inc.	Generation of xenogeneic antibodies
ES2246502T3 (es)	1990-08-29	2006-02-16	Genpharm International, Inc.	Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5545806A (en)	1990-08-29	1996-08-13	Genpharm International, Inc.	Ransgenic non-human animals for producing heterologous antibodies
US5770429A (en)	1990-08-29	1998-06-23	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
US5633425A (en)	1990-08-29	1997-05-27	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en)	1990-08-29	1997-04-29	Genpharm International, Inc.	Transgenic non-human animals for producing heterologous antibodies
US5661016A (en)	1990-08-29	1997-08-26	Genpharm International Inc.	Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
WO1995001997A1 (en)	1993-07-09	1995-01-19	Smithkline Beecham Corporation	RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
CA2165919A1 (en)	1994-12-26	1996-06-27	Koichi Katsuyama	Agents for inhibiting the production of il-1.beta. and the release of tnf.
US5643915A (en) *	1995-06-06	1997-07-01	Andrulis Pharmaceuticals Corp.	Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies
WO1998002441A2 (en)	1996-07-12	1998-01-22	Ariad Pharmaceuticals, Inc.	Non immunosuppressive antifungal rapalogs
IL147803A0 (en)	1999-08-24	2002-08-14	Ariad Gene Therapeutics Inc	28-epirapalogs
GB0001448D0 (en) *	2000-01-21	2000-03-08	Novartis Ag	Organic compounds
EP1282435A2 (en) *	2000-05-12	2003-02-12	Immunex Corporation	Interleukin-1 inhibitors in the treatment of diseases
GB0020685D0 (en) *	2000-08-22	2000-10-11	Novartis Ag	Organic compounds
CN1253449C (zh)	2000-11-07	2006-04-26	诺瓦提斯公司	作为蛋白激酶c抑制剂的吲哚基马来酰亚胺衍生物
EP1478648B1 (en)	2002-02-01	2014-04-30	ARIAD Pharmaceuticals, Inc.	Phosphorus-containing compounds and uses thereof
AR039209A1 (es)	2002-04-03	2005-02-09	Novartis Ag	Derivados de indolilmaleimida
CN100577681C (zh)	2002-07-08	2010-01-06	葛兰素伊斯特拉齐瓦基森塔萨格勒布公司	用于治疗炎性疾病和病症的新化合物、组合物和方法
KR100944575B1 (ko)	2002-10-17	2010-02-25	젠맵 에이/에스	Ｃｄ20에 대한 인간 모노클로날 항체
KR20050084224A (ko)	2002-12-09	2005-08-26	더 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템	야누스 티로신 키나제 3을 선택적으로 저해하는 방법
US7261882B2 (en)	2003-06-23	2007-08-28	Reagents Of The University Of Colorado	Methods for treating neuropathic pain by administering IL-10 polypeptides
ES2389203T3 (es)	2004-01-12	2012-10-24	Ym Biosciences Australia Pty Ltd	Inhibidores de quinasa selectivos
DK1720893T3 (en) *	2004-02-26	2014-11-24	Baylor Res Inst	COMPOSITIONS AND PROCEDURES FOR THE SYSTEMIC TREATMENT OF ARTHRITIS
US7459426B2 (en) *	2004-06-04	2008-12-02	Regeneron Pharmaceuticals, Inc.	Methods of using IL-1 antagonists to treat autoinflammatory disease
GB0417487D0 (en)	2004-08-05	2004-09-08	Novartis Ag	Organic compound
EP2361933A3 (en) *	2005-01-26	2012-05-02	Amgen Fremont Inc.	Antibodies against interleukin-1 beta
ES2335232T3 (es) *	2005-06-21	2010-03-23	Xoma Technology Ltd.	Anticuerpos y fragmentos de los mismos que se unen a la il-1 beta.
EP1940880A2 (en)	2005-10-14	2008-07-09	Novo Nordisk A/S	Treating diabetes using inhibitors of il-1
CA2963828A1 (en) *	2005-10-26	2007-05-03	Novartis Ag	Novel use of il-1beta compounds
WO2008077145A2 (en) *	2006-12-20	2008-06-26	Xoma Technology Ltd.	Treatment of il-1-beta related diseases

2008
- 2008-05-28 WO PCT/EP2008/056520 patent/WO2008145664A1/en not_active Ceased
- 2008-05-28 KR KR1020167002268A patent/KR20160017119A/ko not_active Ceased
- 2008-05-28 KR KR1020197005950A patent/KR20190025056A/ko not_active Ceased
- 2008-05-28 AU AU2008257520A patent/AU2008257520B2/en active Active
- 2008-05-28 EP EP08760116A patent/EP2152308A1/en not_active Ceased
- 2008-05-28 KR KR1020097026864A patent/KR101591533B1/ko active Active
- 2008-05-28 CN CN200880018047A patent/CN101678104A/zh active Pending
- 2008-05-28 MX MX2009012948A patent/MX2009012948A/es not_active Application Discontinuation
- 2008-05-28 KR KR1020187008103A patent/KR20180032687A/ko not_active Ceased
- 2008-05-28 KR KR1020227012190A patent/KR102606597B1/ko active Active
- 2008-05-28 KR KR1020237029637A patent/KR102824865B1/ko active Active
- 2008-05-28 EP EP12158373A patent/EP2468301A1/en not_active Ceased
- 2008-05-28 EP EP18177247.6A patent/EP3406263A1/en not_active Withdrawn
- 2008-05-28 US US12/601,280 patent/US8282922B2/en active Active
- 2008-05-28 CA CA2947947A patent/CA2947947C/en active Active
- 2008-05-28 RU RU2009148597/15A patent/RU2009148597A/ru unknown
- 2008-05-28 CN CN201510324201.1A patent/CN104873972A/zh active Pending
- 2008-05-28 KR KR1020217011722A patent/KR20210047376A/ko not_active Ceased
- 2008-05-28 CA CA3213888A patent/CA3213888A1/en active Pending
- 2008-05-28 EP EP22196860.5A patent/EP4177268A3/en active Pending
- 2008-05-28 CA CA2687499A patent/CA2687499C/en active Active
- 2008-05-28 CA CA3080328A patent/CA3080328C/en active Active
- 2008-05-28 CA CA2993565A patent/CA2993565C/en active Active
- 2008-05-28 JP JP2010509810A patent/JP2010528086A/ja active Pending
- 2008-05-28 CA CA3156905A patent/CA3156905C/en active Active
- 2008-05-28 CA CA3030662A patent/CA3030662C/en active Active
- 2008-05-28 EP EP12158424A patent/EP2468302A1/en not_active Ceased
- 2008-05-28 CA CA3305118A patent/CA3305118A1/en active Pending
- 2008-05-28 BR BRPI0812040-4A2A patent/BRPI0812040A2/pt not_active Application Discontinuation
2012
- 2012-08-17 US US13/587,978 patent/US8524667B2/en active Active
2013
- 2013-07-31 US US13/955,673 patent/US9168298B2/en active Active
2014
- 2014-01-15 RU RU2014101207A patent/RU2698208C9/ru active
- 2014-07-03 JP JP2014137895A patent/JP6454098B2/ja active Active
2015
- 2015-09-22 US US14/861,191 patent/US9534047B2/en active Active
2016
- 2016-07-01 JP JP2016131312A patent/JP2016183187A/ja not_active Withdrawn
- 2016-11-23 US US15/359,784 patent/US10106604B2/en not_active Expired - Fee Related
2018
- 2018-03-07 JP JP2018040956A patent/JP6685339B2/ja active Active
- 2018-09-13 US US16/129,921 patent/US10968272B2/en active Active
2020
- 2020-03-30 JP JP2020060389A patent/JP7069242B2/ja active Active
2021
- 2021-02-26 US US17/186,301 patent/US20210179705A1/en not_active Abandoned
2022
- 2022-05-02 JP JP2022075912A patent/JP7459166B2/ja active Active
2024
- 2024-03-18 JP JP2024042358A patent/JP2024069547A/ja active Pending
2025
- 2025-05-15 US US19/209,316 patent/US20260146083A1/en active Pending

Also Published As

Publication number	Publication date
EP4177268A2 (en)	2023-05-10
EP2468301A1 (en)	2012-06-27
US20130309241A1 (en)	2013-11-21
US10106604B2 (en)	2018-10-23
KR102606597B1 (ko)	2023-11-29
US20120321642A1 (en)	2012-12-20
JP2022093640A (ja)	2022-06-23
CA2947947C (en)	2018-03-06
KR102824865B1 (ko)	2025-06-26
RU2698208C9 (ru)	2019-10-11
CA3080328A1 (en)	2008-12-04
CA3213888A1 (en)	2008-12-04
US9168298B2 (en)	2015-10-27
CA3305118A1 (en)	2026-05-13
KR20210047376A (ko)	2021-04-29
KR20190025056A (ko)	2019-03-08
JP6454098B2 (ja)	2019-01-16
CA3156905A1 (en)	2008-12-04
RU2014101207A (ru)	2015-07-20
CN101678104A (zh)	2010-03-24
CA2993565C (en)	2019-04-02
CA2687499C (en)	2017-11-28
US8524667B2 (en)	2013-09-03
CA2993565A1 (en)	2008-12-04
KR101591533B1 (ko)	2016-02-03
US20190002554A1 (en)	2019-01-03
US20260146083A1 (en)	2026-05-28
US20100166750A1 (en)	2010-07-01
JP7459166B2 (ja)	2024-04-01
MX2009012948A (es)	2009-12-14
JP2018104462A (ja)	2018-07-05
JP2014205706A (ja)	2014-10-30
JP7069242B2 (ja)	2022-05-17
CN104873972A (zh)	2015-09-02
US10968272B2 (en)	2021-04-06
KR20180032687A (ko)	2018-03-30
KR20220050240A (ko)	2022-04-22
WO2008145664A1 (en)	2008-12-04
US8282922B2 (en)	2012-10-09
KR20230130763A (ko)	2023-09-12
CA2687499A1 (en)	2008-12-04
KR20100022082A (ko)	2010-02-26
CA3080328C (en)	2022-06-21
CA3030662C (en)	2020-06-30
US9534047B2 (en)	2017-01-03
JP2020105220A (ja)	2020-07-09
EP2468302A1 (en)	2012-06-27
RU2009148597A (ru)	2011-07-10
US20210179705A1 (en)	2021-06-17
EP2152308A1 (en)	2010-02-17
RU2698208C2 (ru)	2019-08-23
JP2010528086A (ja)	2010-08-19
JP6685339B2 (ja)	2020-04-22
AU2008257520A1 (en)	2008-12-04
EP4177268A3 (en)	2023-05-24
RU2019125748A (ru)	2021-02-15
CA3156905C (en)	2023-11-07
JP2024069547A (ja)	2024-05-21
JP2016183187A (ja)	2016-10-20
RU2019125748A3 (pt)	2022-02-11
US20160002328A1 (en)	2016-01-07
KR20160017119A (ko)	2016-02-15
US20170073411A1 (en)	2017-03-16
CA3030662A1 (en)	2008-12-04
EP3406263A1 (en)	2018-11-28
AU2008257520B2 (en)	2012-04-05
CA2947947A1 (en)	2008-12-04

Legal Events

Date	Code	Title	Description
2015-10-13	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-10-23	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-02-05	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-07-09	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-05-26	B09B	Patent application refused [chapter 9.2 patent gazette]
2020-08-11	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2022-07-12	B350	Update of information on the portal [chapter 15.35 patent gazette]

Publication	Publication Date	Title
BRPI0813497A2 (pt)	2008-12-31	Tampão antisséptico com cobertura para linha
BRPI0818380A2 (pt)	2014-10-07	Combinação de herbicida-protetor
PT2515855E (pt)	2014-06-11	Terapêutica de combinação para dpoc
BRPI0813670A2 (pt)	2014-12-30	Compostos para tratamento
PA8805201A1 (es)	2010-02-12	Piperidinas heteroaril-sustituidas
AT505058A3 (de)	2008-12-15	Türschliesssystem
BRPI0818598A2 (pt)	2017-05-16	agentes terapêuticos - 802
BRPI0820410A2 (pt)	2015-05-19	Lactans substituídos terapêuticos
BRPI0807984A2 (pt)	2014-06-24	Unidade de distribuição
EP2227553A4 (en)	2011-01-19	Lac expression system
BRPI0918508A2 (pt)	2015-12-08	orto-aminoanilidas para o tratamento de câncer
BRPI0812105A2 (pt)	2014-11-25	Neramexano para o tratamento de nistagmo
ES1065457Y (es)	2007-11-16	Dispositivo de amortiguacion para quads
ES1064720Y (es)	2007-07-16	Guia para persiana
ES1064958Y (es)	2007-08-16	Soporte para mechero
ES1065835Y (es)	2008-02-16	Caperuza para cetreria
ES1066267Y (es)	2008-04-01	Soporte para protesis
DE112007003477A5 (de)	2010-01-28	Schutzgerät
DE112007003228A5 (de)	2009-12-24	Temperiervorrichtung
ES1066084Y (es)	2008-03-16	Poliedro tetraedro desmontable
AT9563U3 (de)	2008-05-15	Wirbelsäulenzuggurtung
AT504425B1 (de)	2008-05-15	Portioniersteuerung
ES1063735Y (es)	2007-03-01	Testero para persiana
ES1065263Y (es)	2007-10-16	Captafaros para bionda
ES1062659Y (es)	2006-10-01	Estructura para cubiertas